Turning the tide on tuberculosis: a combined effort
The many sponsors of tuberculosis drugs must work together to find new effective treatments, says Mel Spigelman. Tuberculosis (TB) —
The many sponsors of tuberculosis drugs must work together to find new effective treatments, says Mel Spigelman. Tuberculosis (TB) —
Major deficiencies in developing, supplying, and distributing anti-tuberculosis drugs is hampering the global effort to control the disease, according to
Andrew Speaker, an Atlanta lawyer infected with a highly drug-resistant strain of tuberculosis (XDR-TB), ignited a media firestorm and a
A private-public partnership to establish a not-for-profit research organization focused the discovery of drugs to treat resistant strains of tuberculosis
Tuberculosis has been flying under the American radar for decades now, as it has lost its status as a top
Hundreds of thousands of cases of drug-resistant tuberculosis (TB) can be prevented and as many as 134,000 lives saved through
Seattle, WA – Eli Lilly and Company (NYSE: LLY) today announced the creation of an ambitious public-private partnership to conduct
SEATTLE, June 13 (Reuters) – Eli Lilly and Co. has joined forces with U.S. health experts in the search for
The Global Alliance for TB Drug Development (TB Alliance), a not-for-profit, product development partnership accelerating the discovery and development of
With the whole world wagging its collective finger at Andrew Speaker–the TB-infected lawyer who triggered a global health scare last